Target intelligence / Profile preview

Plasmodium falciparum Sporozoite (Late Liver Stage)

Molecular classification: Parasite, Protozoan

Overview

Plasmodium falciparum sporozoites in the late liver stage represent a critical target for antimalarial interventions. This stage involves the maturation of the parasite within hepatocytes, culminating in the release of merozoites that initiate the symptomatic blood stage of malaria. Targeting this stage can prevent the establishment of clinical disease.

Mechanism of action

Target of drugs that inhibit parasite development in the liver, preventing blood-stage infection.

Biological functions

ReplicationMaturationInfection

Disease associations

Malaria

Safety considerations

Potential for drug resistance development.

Beyond the preview

Go deeper on Plasmodium falciparum Sporozoite (Late Liver Stage).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium falciparum Sporozoite (Late Liver Stage).

Explore the full profile